CRNC, US1567271093

Cerence stock reports AI revenue growth after lawsuit deal!?? not supposed

Published on 10/05/2026 at 10:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cerence stock faces a legal reset after a Microsoft lawsuit deal on October 2, while fiscal Q3 revenue reached USD 69.587 million. Zacks lists a USD 10.75 average target.

CRNC, US1567271093, Illustration mit AI erstellt.
CRNC, US1567271093, Illustration mit AI erstellt.

Cerence stock (ISIN US1567271093) was last at USD 8.09 on Nasdaq on October 2, 2026, giving the company a market capitalization of USD 365.6 million. The latest legal development is a settlement deal with Microsoft that ends Cerence's Delaware copyright lawsuit, according to Law360 on October 2, 2026.

Microsoft deal changes the legal picture

The dispute involved text-to-speech technology and had placed a legal issue alongside Cerence's effort to expand artificial intelligence software beyond traditional in-car assistants. The settlement removes that specific court conflict from the near-term company narrative, although its financial effect was not stated in the cited report.

Cerence's latest reported quarter ended June 30, 2026. Revenue was USD 69.587 million, net income attributable to common shareholders was USD 1.533 million and diluted earnings per share were USD 0.03, according to the company's investor-relations page and the Q3 fiscal 2026 data shown by Yahoo Finance. The operating margin was 3 percent for that quarter.

Revenue growth meets cash generation

Cerence reported on August 6, 2026, that third-quarter revenue increased 12 percent year over year and connected-services revenue increased 20 percent. Operating cash flow reached USD 20 million, supporting the company's first share-repurchase program.

The mix matters because connected services rose faster than total revenue, making recurring software usage an important measure for the next phase of the business. The June-quarter operating cash flow also provides a counterweight to the legal headline: cash generation was positive, but investors still have to distinguish recurring service growth from license timing.

Analysts see room above the last price

Zacks lists a 2.67 average brokerage recommendation based on six firms and a USD 10.75 average price target from four analysts. The target range is USD 9.00 to USD 12.00, and the average target lies 32.9 percent above the USD 8.09 last price.

The market is therefore weighing three separate figures: USD 69.587 million in quarterly revenue, USD 20 million in operating cash flow and a USD 10.75 analyst average target. CRNC's 52-week range was USD 5.85 to USD 13.49 as of October 2, 2026.

CRNC stock stays below its yearly high

CRNC was last at USD 8.09 on Nasdaq at 4:00 p.m. ET on October 2, 2026, down USD 0.01, or 0.12 percent, from the prior close of USD 8.10. The stock remains 40.0 percent below its 52-week high of USD 13.49.

Cerence stock key figures

  • Company: Cerence Inc.
  • ISIN: US1567271093
  • Ticker: CRNC
  • Trading venue: Nasdaq
  • Price (as of October 2, 2026, 4:00 p.m. ET): USD 8.09
  • Market capitalization: USD 365.6 million (as of October 2, 2026)
  • 52-week range: USD 5.85-13.49 (as of October 2, 2026)
  • Sector / Industry: Information technology / software

More news and analyses on Cerence stock

Disclaimer...

en | US1567271093 | CRNC | boerse | 70231371 | bgmi